Argenica Therapeutics Ltd (AGN) - Total Liabilities

Latest as of December 2025: AU$1.76 Million AUD ≈ $1.24 Million USD

Based on the latest financial reports, Argenica Therapeutics Ltd (AGN) has total liabilities worth AU$1.76 Million AUD (≈ $1.24 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Argenica Therapeutics Ltd (AGN) cash flow conversion to assess how effectively this company generates cash.

Argenica Therapeutics Ltd - Total Liabilities Trend (2019–2024)

This chart illustrates how Argenica Therapeutics Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Argenica Therapeutics Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Argenica Therapeutics Ltd Competitors by Total Liabilities

The table below lists competitors of Argenica Therapeutics Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Middle Island Resources Ltd AU:MDI	Australia	AU$177.43K
Mega Polietilen Kopuk Sanayi ve Ticaret AS IS:MEGAP	Turkey	TL1.22 Billion
Janfusun Fancyworld TWO:5701	Taiwan	NT$1.92 Billion
RPCG Public Company Limited BK:RPC	Thailand	฿5.21 Billion
MyTech Group Bhd KLSE:7692	Malaysia	RM1.46 Million
Cubex Tubings Limited NSE:CUBEXTUB	India	Rs726.86 Million
Immo Moury SICAF Immobiliere Publique de Droit Belge BR:IMMOU	Belgium	€22.80 Million
Torrent Capital Ltd V:TORR	Canada	CA$1.42 Million

Liability Composition Analysis (2019–2024)

This chart breaks down Argenica Therapeutics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Argenica Therapeutics Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.51	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.34	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Argenica Therapeutics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Argenica Therapeutics Ltd (2019–2024)

The table below shows the annual total liabilities of Argenica Therapeutics Ltd from 2019 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$3.80 Million ≈ $2.69 Million	+56.66%
2023-12-31	AU$2.43 Million ≈ $1.72 Million	+29.46%
2022-12-31	AU$1.87 Million ≈ $1.33 Million	+154.71%
2021-12-31	AU$735.91K ≈ $520.70K	+72.86%
2020-12-31	AU$425.72K ≈ $301.22K	+18.50%
2019-12-31	AU$359.26K ≈ $254.20K	--

About Argenica Therapeutics Ltd

AU:AGN Australia Biotechnology

Market Cap

$15.45 Million

AU$21.84 Million AUD

Market Cap Rank

#25743 Global

#1180 in Australia

Share Price

AU$0.17

Change (1 day)

+0.00%

52-Week Range

AU$0.14 - AU$0.83

All Time High

AU$0.99